DUBLIN, March 10, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first generic version of Allergan's Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) 140 mg, 125 mg and 125 mg capsules in the U.S., following final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application.
India, long associated with the spread of superbug New Delhi metallo-beta lactamase-1 and extensively drug-resistance tuberculosis, has now been identified as one of the global hotspots of rising antibiotic resistance among animals as well.
MENLO PARK, Calif., March 20, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced the U.S. Patent and Trademark Office has granted the first in what the company expects will be a new family of patents protecting its novel topical gel delivery system that allows for greater bioavailability of an active pharmaceutical ingredient (API) .
Enforcement Report - Week of July 12, 2017
Phillips Company Issues Voluntary Worldwide Recall of All Topical Products
Although the 73-year-old knows there's no cure for her disease, she wants researchers to do better. It's been years, she said, since she has found a drug that has actually helped. McCarthy said she's frustrated that the Food and Drug Administration is approving cancer drugs without proof that they cure patients or help them live longer.
Antibiotic Overuse Finds Long Trail Across Schoolchildren In East China, Study Says
IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?